Broadwind's profit lacks free cashflow support, indicating potentially lower underlying earnings power. Despite recent profit, future profitability is questionable due to high accrual ratio and negative free cash flow.
Analysts show optimism for losses per share despite falling revenue estimates. Broadwind's revenues are expected to underperform the wider industry, leading to increased pessimism about the business's intrinsic value.
Broadwind股票讨论区
Broadwind stock rises ~14% after hours on higher-than-expected prelim. Q1 revenue
Stock Market Insights | Seeking Alpha
$American Virtual(AVCT.US)$ $BIT Mining(BTCM.US)$ $Broadwind(BWEN.US)$ $Catalyst Biosciences(CBIO.US)$ $Direct Digital(DRCT.US)$ $Galera Therapeutics(GRTX.US)$ $HEXO Corp(HEXO.US)$ $摩根大通(JPM.US)$ $Linde(LIN.US)$ $MGO Global(MGOL.US)$ $Oramed Pharmaceuticals(ORMP.US)$ $Rivian Automotive(RIVN.US)$ $Shuttle Pharmaceuticals(SHPH.US)$ $联合利华(英国)(UL.US)$
暂无评论